Table 2.
Levels of enzymic and non-enzymic antioxidants in the liver of various groups
| Groups | LPOa | SODb | CATc | GPxd | GSHe | Vitamin Cf |
|---|---|---|---|---|---|---|
| I | 0.80 ± 0.08 | 12.35 ± 2.23 | 68.46 ± 8.48 | 6.47 ± 0.94 | 1.93 ± 0.30 | 4.01 ± 0.39 |
| II | 2.47 ± 0.15* | 6.07 ± 2.81* | 34.01 ± 8.82* | 4.40 ± 0.27* | 0.73 ± 0.28* | 2.28 ± 0.23* |
| III | 1.40 ± 0.07* | 8.85 ± 0.22* | 49.12 ± 6.14* | 5.94 ± 1.83** | 1.47 ± 0.28* | 2.88 ± 0.21* |
| IV | 1.32 ± 0.15* | 9.63 ± 2.21* | 59.36 ± 8.85* | 6.02 ± 1.78** | 1.65 ± 0.35* | 3.11 ± 0.26* |
| V | 0.97 ± 0.09 | 12.19 ± 2.89 | 63.80 ± 8.66 | 6.39 ± 1.05 | 1.93 ± 0.30 | 3.82 ± 0.22 |
| VI | 0.75 ± 0.08 | 12.27 ± 2.10 | 68.41 ± 6.92 | 6.29 ± 1.00 | 2.02 ± 0.45 | 3.82 ± 0.23 |
| LSD(1%)0.17 | LSD(1%)3.58 | LSD(1%)12.77 | LSD(5%)1.49 LSD(1%)2.00 | LSD(1%)0.52 | LSD(1%)0.42 |
Values are mean ± SD (n = 6)
Statistical significance are as follows: * P < 0.01, ** P < 0.05
Comparisons between groups are as follows
Group I versus Group II; Group II versus Group III and Group IV; Group I versus Group V and Group VI; a μmoles/g tissue; b U/mg protein (amount of enzyme required to inhibit 50% reduction of NBT); c U/mg protein (μm of H2O2 decomposed/min/mg protein); d U/mg protein (μ moles of GSH consumed/min/mg protein); e μg/mg protein; fμg/mg protein